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Abstract
Objective. To assess the outcome of laparoscopic cholecystectomy on the basis of an abnormal provocative 99mtechnetium-
labelled hepato imino diacetic acid (HIDA) scan for patients with typical biliary pain and normal trans-abdominal
ultrasound (TUS) scan. Patients and methods. Prospective data were collected for 1201 consecutive patients with typical
biliary symptoms. Patients who were found to have a normal TUS and upper GI endoscopy subsequently underwent
cholescintigraphy (HIDA scan). Patients with an abnormal HIDA scan, i.e.B40% ejection fraction with Sincalide†
(cholecystokinin octapeptide)  were offered cholecystectomy. Symptoms and histology were reviewed postoperatively.
Results. In all, 48/1201 (4%) patients with typical biliary symptoms had a normal ultrasound and endoscopy; 35/48 patients
had an abnormal provocative HIDA scan and all underwent laparoscopic cholecystectomy. Histology in all cases revealed
chronic cholecystitis and 18 patients had sludge or microlithiasis within the gallbladder. At 6-week follow-up, 31 of the 35
patients were completely asymptomatic or improved. Furthermore, 79% of patients remained symptom-free or improved at
a median follow-up of 28.5 months (range 470). Conclusions. HIDA scan is a useful clinical tool as an adjunct to the
diagnosis and management of patients who present with typical biliary pain and a normal TUS scan.
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Introduction
Symptoms from gallbladder pathology are a common
cause of surgical admissions. Trans-abdominal ultra-
sonography (TUS) is the standard investigation for
the detection of gallstones [1]. Patients with typical
biliary pain but a normal TUS scan are often under-
investigated. TUS for cholelithiasis is recognized
to have a false negative rate of 25%, with reduced
sensitivity for the detection of very small stones
and choledocholithiasis. In addition, the concepts of
acalculous cholecystitis or gallbladder dyskinesia have
been described for many decades [2,3]. Gallbladder
spasm, distension or mal-coordination between con-
tractions in the gallbladder, cystic duct and sphincter
of Oddi may cause pain. Biliary stasis as a result of
gallbladder dysmotility may result in chemical irrita-
tion and chronic inflammation of the gallbladder wall.
Evidence for the benefit of cholecystectomy for those
with biliary colic but without stones was first reported
by Whipple in 1922, with 76% symptom resolution on
long-term follow-up [4].
The options for further investigation of patients
with typical bilary symptoms but a negative TUS
include endoscopic ultrasonography and radionucleo-
tide scanning. Endoscopic ultrasonography demon-
strates increased sensitivity over trans-abdominal
scanning for structural abnormalities such as gall-
bladder sludge, microlithiasis and choledocholithiasis.
The provocative oral cholecystogram [5] led the way
to dynamic assessment of gallbladder function, with
provocative radionuclide cholescinthigraphy being
preferred more recently [611]. Radionuclide scan-
ning using 99mtechnetium-labelled hepato imino dia-
cetic acid (HIDA) has been available for over a
decade but its use in diagnostic work-up of patients
with biliary symptoms has not yet become routine
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[79]. Provocative HIDA scan with infusion of
cholecystokinin octapeptide is preferred in most units,
although the rate of infusion has been different in
most published literature with various authors pre-
ferring anything from 3 to 30 min [1214].
This study reviews the value of HIDA scan in the
assessment of patients with biliary pain and their
outcome after laparoscopic cholecystectomy.
Patients and methods
From October 1998 to June 2005, 1201 patients with
typical biliary symptoms were referred to the Hepa-
tobiliary Unit of St James’s University Hospital,
Leeds. Patient data were prospectively entered on
a database. All patients were initially investigated by
TUS. Patients with demonstrable cholelithiasis on
TUS underwent laparoscopic cholecystectomy. If the
TUS did not show any gallstones, sludge, thick wall
or dilated ducts, alternative upper gastrointestinal
pathologies were excluded by endoscopy.
If both the TUS and the endoscopy were normal, a
provocative HIDA scan was performed (Figure 1).
Dynamic acquisition of images over 180 frames at
15 s each was performed. Normal saline was injected
as a control between frames 11 and 30, and 1.4 mg
Sincalide† (cholecystokinin octapeptide or CCK-OP)
was administered by slow intravenous injection
over a duration of 5 min between frames 50 and 70.
The duration of 5 min has been used in our institu-
tion based on our normal ranges on outcomes for
20 years. Gallbladder emptying was assessed and the
gallbladder ejection fraction (GBEF) was calculated.
Patients with an abnormal HIDA scan, defined as
GBEFB40% with CCK-OP, were offered cholecys-
tectomy (Figure 2). Patients with a normal HIDA
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Figure 1. Cholescintigraphy using 99mHIDA to demonstrate gallbladder ejection fraction (GBEF). (A) Initially 99mHIDA accumulates in
the gallbladder (GB) prior to stimulation with cholecystokinin-octapeptide (CCK-OP). A normal response shows complete gallbladder
emptying with efflux of 99mHIDA into the small intestine 20 mins after stimulation with CCK-OP. Dyskinesia of the gallbladder results in
pronounced retention of 99mHIDA in the gallbladder despite stimulation with CCK-OP. (B) Response curves generated by quantitation of
99mHIDA levels in the gallbladder. In the normal gallbladder, the radionuclide count rapidly decreases over the gallbladder after
administration of sincalide and the fraction that has been ejected is expressed as a percentage of the initial radionuclide count. In the
dyskinetic gallbladder, the administration of sincalide fails to result in ejection of the 99mHIDA even after 40 minutes. Quantitation of
99mHIDA levels in the gallbladder after stimulation with CCKOP are used to calculate the GBEF, with significant abnormality in response
resulting in a GBEFB40%.
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scan were referred to medical gastroenterology and
only re-assessed by the surgical team if their symp-
toms failed to resolve.
Patients who were offered laparoscopic cholecystect-
omy were clinically reviewed postoperatively at 6 weeks
by the senior author. All patients were contacted
by telephone in October 2005 by authors, S.F. and
C.R.C., for a clinical review to re-evaluate symptoms.
Patients were asked whether their symptoms were
completely resolved, improved or unchanged. If un-
changed they were asked whether an alternative diag-
nosis or treatment had been given (Table I).
The histology of the post cholecystectomy gallblad-
ders was assessed by a specialist hepatobiliary patho-
logy team. The results were compared with the
histology of a historical cohort of 20 gallbladders
removed as part of routine hepatectomy or liver graft
implantation as a negative control, again reviewed by
the same hepatobiliary pathology team. The pathol-
ogists were aware of the clinical diagnosis in all cases,
including the control group.
Results
Forty-eight patients (4%) had no gallstones on TUS
and a normal upper gastrointestinal endoscopy and
subsequently underwent HIDA scanning.
Outcome after laparoscopic cholecystectomy in patients
with GBEFB40%
Thirty-five patients (10 male, 25 female; median
age 46 years, range 1780) had a GBEFB40% and
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Figure 2. The investigation and management of biliary pain. The absence of cholelithiasis on investigation of typical biliary pain by trans-
abdominal ultrasound should prompt investigation into alternative upper GI pathology by endoscopy. Cholescintigraphy is then performed
to assess gallbladder ejection fraction (GBEF). Patients with GBEFB40% should undergo laparoscopic cholecystectomy.
Table I. Questions for assessment of continued symptoms during
follow-up.
Questions asked at follow-up
Do you have any abdominal pain?
Is it the same pain that you had before your operation?
If yes  Is it better, the same or worse than the pain before
your operation?
If no  Have you seen any other doctor about the pain?
Have you been given another diagnosis for the pain?
Have you had any other treatment for the pain?
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subsequently underwent laparoscopic cholecystect-
omy. All patients had normal liver function tests
preoperatively. Routine peroperative cholangiogram
was performed in all except one patient who was
known to have contrast allergy. All operations were
successfully completed laparoscopically.
At 6-week clinic review, 31 of the 35 patients
reported significant improvement in their symptoms,
and 27 patients were completely symptom-free. Four
patients remained symptomatic. All patients were
contacted by telephone in October 2005 for re-
assessment (median follow-up of 28.5 months, range
470). Six patients were lost to follow-up and one
patient died due to disseminated colonic carcinoma
15 months after laparoscopic cholecystectomy. These
seven patients were symptom-free at the 6-week clinic
review. Of the remaining 28 patients, 22 patients
reported improvement, with 19 completely asympto-
matic. Six patients reported continued symptoms, five
of whom had also reported continued symptoms at
the 6-week clinic review. Two of these patients were
finally diagnosed with irritable bowel syndrome and
four continue to be investigated including assessment
for sphincter of Oddi dysfunction.
Eighteen patients with a GBEFB40% on HIDA
scan had evidence of sludge or microlithiasis at
operation. All post cholecystectomy gallbladders
showed histological evidence of chronic cholecystitis
compared with the negative control group, which all
had normal histology except for one with mild chronic
cholecystitis.
Outcomes in patients with GBEF40%
Thirteen patients had GBEF40% on HIDA scan.
These patients were referred to medical gastroenter-
ology and were also followed up by telephone clinical
review. Four patients reported spontaneous improve-
ment in their symptoms. Nine patients reported
continued biliary symptomatology, of whom six have
subsequently undergone laparoscopic cholecystect-
omy with full resolution of their symptoms. All six
gallbladders demonstrated histological evidence of
chronic cholecystitis. One patient (with co-morbid-
ities of hepatitis C, cirrhosis and varices) re-presented
with acute cholecystitis and eventually underwent
open cholecystectomy.
Discussion
Prior to the discovery of oral cholecystography
(OCG) by W.H. Cole [5] in 1923, surgeons relied
on symptomatology to make a decision to remove the
gallbladder. Oral cholecystogram proved to be bene-
ficial in identifying symptomatic gallbladders. Gall-
stones, polyps, adenomyosis and occasionally cancer
could be visualized in the opacified gallbladder [15]
and the persistence of gallbladder opacification after
24 h was considered an indication for cholecystect-
omy [16]. Subsequently the cholecystokinin provoca-
tion test [2] was used to reproduce biliary colic as a
pharmacodiagnostic agent in those with no convin-
cing stones on OCG, but its efficacy was found to be
questionable [17]. Cholecystokinin stimulation has
been used in conjunction with both OCG and
dynamic ultrasound scan [18] but the standardization
of results has proven difficult [19]. Freeman et al.
combined this with duodenal bile analysis to create
a protocol for cholecystectomy based on poor empty-
ing of gallbladder and presence of supersaturated bile
[20]. Biliary excretion studies using 99mtechnetium-
labelled HIDA, with subsequent provocation either
with cholecystokinin analogue or various forms
of fatty meal, have been used since the late 1970s
[69,21]. The major advantages of such studies over
other investigations of gallbladder function are their
reproducibility and lack of operator dependence [10].
There is no consensus regarding the duration of
infusion, with various authors preferring anything
from 5 min to 60 min based on personal experience
[1214]. Reproducibility studies with various doses
and duration of infusion are few in the literature [22],
but with no clear-cut indication as to the optimum
duration or ideal dose. Our experiences with the
5 min infusion have been that it avoids the high
peak of serum concentration leading to the unreliable
response often seen with bolus infusion and with no
disadvantages compared to the 30 min infusion.
While HIDA scan is accepted as an accurate and
reproducible method of demonstrating gallbladder
dysfunction or dyskinesia, there is currently no con-
sensus regarding the level of dysfunction (indicated by
the ejection fraction or GBEF) at which cholecystect-
omy may be reliably beneficial. Clinical improvement
after cholecystectomy in patients with gallbladder
dysfunction has been demonstrated by a number
of studies, but the use of a variety of doses and
administration regimes of CCK-OP makes compar-
ison between these studies difficult to interpret
and subsequent definitions of abnormal GBEF
vary between 35 and 65% [23]. In this study, a
GBEF ofB40% was used, corresponding to levels
defined by the Rome II Committee on Biliary
Dyskinesia. Although CCK-OP infusion has been
associated with reproduction of biliary colic, there is
evidence that this is not reliable [12,13,24] and hence
we have not attempted to correlate the reproducibility
of clinical symptoms with infusion of CCK-OP.
HIDA scan has so far been used predominantly to
diagnose dyskinetic gallbladder in those deemed to be
acalculous on ultrasound scan. Accuracy of TUS scan
is operator- and patient-dependent, with a reported
false negative rate of 25% and reduced sensitivity
for choledocholithiasis and the presence in the gall-
bladder of sludge or calculi smaller than 35 mm.
Endoscopic ultrasound demonstrates increased sensi-
tivity for structural disease but may also be operator-
dependent and gives no indication of gallbladder
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function. Dill et al. [25] reported the identification of
microlithiasis or biliary sludge by endoscopic ultra-
sound in 58 out of a series of 66 patients (88%) who
had typical biliary symptoms and negative TUS. In
the study presented here, half the patients with
abnormal HIDA scans demonstrated sludge in the
gallbladder at operation and this is consistent with
other studies documenting abnormal gallbladder
motility in the presence of gallstones [2629]. How-
ever, half of the patients with documented gallbladder
dysmotility on HIDA scan in this study had no
evidence of biliary sludge and would have not
benefited from endoscopic ultrasonography.
All gallbladders in this series with or without sludge
showed evidence of chronic cholecystitis, while others
have reported a 7090% incidence of chronic chole-
cystitis in similar series [3035]. The aetiology of
the chronic inflammation in these gallbladders is
unclear. Gallbladder dysfunction causing biliary stasis
is thought to contribute to chronic cholelithiasis in
up to 70% of patients with symptomatic disease and is
confined to cases where bile is supersaturated with
cholesterol. Excess cholesterol incorporates into the
plasma membrane of the smooth muscle cells in the
gallbladder wall affecting muscular contractility with
the resulting biliary stasis and cholelithiasis (macro- or
microscopic) causing chronic inflammation. Conver-
sely, the inflammatory process itself, acute or chronic,
may contribute to dysfunction of the muscular
gallbladder wall. There are conflicting reports regard-
ing the proportion of histologically inflamed gallblad-
ders in asymptomatic acalculous gallbladders. Our
review of control gallbladders showed that only 1 of
20 showed any sign of inflammation and therefore
suggests that the universal pathological inflammation
reported in this study is related to symptoms in both
the HIDA-positive and -negative patients.
In this study, 89% of patients with an abnormal
HIDA scan had symptomatic relief or improvement
at 6-week clinic review. Seven patients were lost to
long-term follow-up (including one death) but were
all asymptomatic at 6 weeks. In all, 79% of the
remaining patients were asymptomatic or improved
at long-term follow-up. This study also provides
limited evidence, corroborated by other reports in
the literature [23,37], suggesting that some patients
with typical biliary symptoms and normal HIDA scan
may also benefit from cholecystectomy. However, all
these studies have followed very small numbers
of patients. Patients with typical biliary symptoms
and a negative ultrasound, endoscopy and HIDA
scan require extensive investigation and a period of
observation before committing to this course of
action.
This is the largest reported series in the UK of
patients undergoing cholecystectomy on the basis
of an abnormal HIDA scan. The results compare
favourably with other international studies [30
36,38] and show that the HIDA scan is a very useful
tool in early diagnosis of biliary pain in those patients
who have a normal TUS scan. HIDA scan provides
the clinician with a simple, reproducible, non-invasive
and objective test before proceeding with surgery.
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